IL1B and colitis: Lai et al. (2022) discovered that the lipopolysaccharide (LPS) of PG could reduce the levels of the pro-inflammatory cytokines IL-1β and TNF-α in mice with colitis, mitigate inflammatory damage, and maintain the integrity of the intestinal epithelium, demonstrating its anti-inflammatory effects in mice [18].